Abstract
Pharmacotherapy is the conventional treatment for depression, with only half of the patients responding to the first trial of monotherapy with first-line medicines. One way to overcome this resistance is to use complementary and alternative medicine. The antidepressant effects of Lavandula angustifolia, which is commonly called lavender, have been investigated in previous studies. This study aims to provide the first systematic review of lavender in treating patients with depression diagnosis. ISI Web of Science, Scopus, PubMed, Embase, PsycINFO, Google Scholar, and three trial registries were searched until May 2020 to find randomized controlled trials on lavender for depressed patients. The primary outcome was difference between the intervention and control groups in changing depression scores from baseline to endpoint. The included studies were assessed for effect size and methodological quality. Seven clinical trials were identified, in which 852 patients were studied. In six trials, the effectiveness of lavender in treating depression was reported, as being more pronounced adjunct to a typical antidepressant in one study. Significant reported side effects include headaches and eructation. Lavender is beneficial, tolerable, and safe in treating depression. Despite obtaining promising results, they are not enough to recommend prescribing lavender to depressed patients. Further high-quality, large-scale studies for rectifying the shortcomings of existing studies are recommended.
Acknowledgments
This study is the postgraduate thesis of Dr. Ahmad Shamabadi. Its protocol was registered and approved on April 17, 2020, at Tehran University of Medical Sciences under IR.TUMS.VCR.REC.1399.258.
-
Research funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
-
Author contributions: AS: Searching, data collection, interpretation, writing. SA: Principal investigation, data collection, interpretation.
-
Competing interests: The authors have no conflict of interest.
References
1. Costello, CG, Scott, CB. Primary and secondary depression: a review. Can J Psychiatr 1991;36:210–7. https://doi.org/10.1177/070674379103600310.Search in Google Scholar PubMed
2. James, SL, Abate, D, Abate, KH, Abay, SM, Abbafati, C, Abbasi, N, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7.Search in Google Scholar PubMed PubMed Central
3. Lam, RW, McIntosh, D, Wang, J, Enns, MW, Kolivakis, T, Michalak, EE, et al.. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 1. Disease burden and principles of care. Can J Psychiatr 2016;61:510–23. https://doi.org/10.1177/0706743716659416.Search in Google Scholar PubMed PubMed Central
4. Otte, C, Gold, SM, Penninx, BW, Pariante, CM, Etkin, A, Fava, M, et al.. Major depressive disorder. Nat Rev Dis Primers 2016;2:16065. https://doi.org/10.1038/nrdp.2016.65.Search in Google Scholar PubMed
5. Bachmann, S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Publ Health 2018;15:1425. https://doi.org/10.3390/ijerph15071425.Search in Google Scholar PubMed PubMed Central
6. Unies, N. World population prospects: the 2017 revision. New York, United Nations: Department of Economic and Social Affairs, Population Division; 2017.Search in Google Scholar
7. WHO, G. WHO methods and data sources for global burden of disease estimates 2000–2011. Geneva: Department of Health Statistics and Information Systems; 2013.Search in Google Scholar
8. Eaton, WW, Martins, SS, Nestadt, G, Bienvenu, OJ, Clarke, D, Alexandre, P, et al.. The burden of mental disorders. Epidemiol Rev 2008;30:1–14. https://doi.org/10.1093/epirev/mxn011.Search in Google Scholar PubMed PubMed Central
9. Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ, Ogawa, Y, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391:1357–66. https://doi.org/10.1016/s0140-6736(17)32802-7.Search in Google Scholar
10. Nabavi, SM, Daglia, M, Braidy, N, Nabavi, SF. Natural products, micronutrients, and nutraceuticals for the treatment of depression: a short review. Nutr Neurosci 2017;20:180–94. https://doi.org/10.1080/1028415x.2015.1103461.Search in Google Scholar
11. Hashimoto, K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009;61:105–23. https://doi.org/10.1016/j.brainresrev.2009.05.005.Search in Google Scholar PubMed
12. Deutschenbaur, L, Beck, J, Kiyhankhadiv, A, Muhlhauser, M, Borgwardt, S, Walter, M, et al.. Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog Neuro-Psychopharmacol Biol Psychiatry 2016;64:325–33. https://doi.org/10.1016/j.pnpbp.2015.02.015.Search in Google Scholar PubMed
13. Kohler, O, Krogh, J, Mors, O, Benros, ME. Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol 2016;14:732–42. https://doi.org/10.2174/1570159x14666151208113700.Search in Google Scholar PubMed PubMed Central
14. Dome, P, Tombor, L, Lazary, J, Gonda, X, Rihmer, Z. Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review. Brain Res Bull 2019;146:51–78. https://doi.org/10.1016/j.brainresbull.2018.12.015.Search in Google Scholar PubMed
15. Shamabadi, A, Akhondzadeh, S. Advances in alternative and integrative medicine in the treatment of depression: a review of the evidence. Arch Iran Med 2021;24:409–18. https://doi.org/10.34172/aim.2021.59.Search in Google Scholar PubMed
16. Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al.. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can J Psychiatr 2016;61:540–60. https://doi.org/10.1177/0706743716659417.Search in Google Scholar PubMed PubMed Central
17. Pietrzak, RH, Kinley, J, Afifi, TO, Enns, MW, Fawcett, J, Sareen, J. Subsyndromal depression in the United States: prevalence, course, and risk for incident psychiatric outcomes. Psychol Med 2013;43:1401–14. https://doi.org/10.1017/s0033291712002309.Search in Google Scholar
18. Ravindran, AV, Balneaves, LG, Faulkner, G, Ortiz, A, McIntosh, D, Morehouse, RL, et al.. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 5. Complementary and alternative medicine treatments. Can J Psychiatr 2016;61:576–87. https://doi.org/10.1177/0706743716660290.Search in Google Scholar PubMed PubMed Central
19. Sarris, J, Murphy, J, Mischoulon, D, Papakostas, GI, Fava, M, Berk, M, et al.. Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatr 2016;173:575–87. https://doi.org/10.1176/appi.ajp.2016.15091228.Search in Google Scholar PubMed
20. El-Alfy, AT, Abourashed, EA, Matsumoto, RR. Nature against depression. Curr Med Chem 2012;19:2229–41. https://doi.org/10.2174/092986712800229096.Search in Google Scholar PubMed
21. Cavanagh, HM, Wilkinson, JM. Biological activities of lavender essential oil. Phytother Res 2002;16:301–8. https://doi.org/10.1002/ptr.1103.Search in Google Scholar PubMed
22. de Groot, A, Schmidt, E. Essential oils, Part V: peppermint oil, lavender oil, and lemongrass oil. Dermatitis 2016;27:325–32. https://doi.org/10.1097/der.0000000000000218.Search in Google Scholar PubMed
23. Cardia, GFE, Silva-Filho, SE, Silva, EL, Uchida, NS, Cavalcante, HAO, Cassarotti, LL, et al.. Effect of lavender (Lavandula angustifolia) essential oil on acute inflammatory response. Evid Base Compl Alternative Med 2018;2018:1413940. https://doi.org/10.1155/2018/1413940.Search in Google Scholar PubMed PubMed Central
24. Hritcu, L, Cioanca, O, Hancianu, M. Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012;19:529–34. https://doi.org/10.1016/j.phymed.2012.02.002.Search in Google Scholar PubMed
25. Rahmati, B, Kiasalari, Z, Roghani, M, Khalili, M, Ansari, F. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats. Pharm Biol 2017;55:958–65. https://doi.org/10.1080/13880209.2017.1285320.Search in Google Scholar PubMed PubMed Central
26. Lopez, V, Nielsen, B, Solas, M, Ramirez, MJ, Jager, AK. Exploring pharmacological mechanisms of lavender (Lavandula angustifolia) essential oil on central nervous system targets. Front Pharmacol 2017;8:280. https://doi.org/10.3389/fphar.2017.00280.Search in Google Scholar PubMed PubMed Central
27. Baldinger, P, Hoflich, AS, Mitterhauser, M, Hahn, A, Rami-Mark, C, Spies, M, et al.. Effects of silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. Int J Neuropsychopharmacol 2015;18. https://doi.org/10.1093/ijnp/pyu063.Search in Google Scholar PubMed PubMed Central
28. Ialongo, C. Understanding the effect size and its measures. Biochem Med 2016;26:150–63. https://doi.org/10.11613/BM.2016.015.Search in Google Scholar PubMed PubMed Central
29. Jadad, AR, Moore, RA, Carroll, D, Jenkinson, C, Reynolds, DJM, Gavaghan, DJ, et al.. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Contr Clin Trials 1996;17:1–12. https://doi.org/10.1016/0197-2456(95)00134-4.Search in Google Scholar PubMed
30. Olivo, SA, Macedo, LG, Gadotti, IC, Fuentes, J, Stanton, T, Magee, DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 2008;88:156–75. https://doi.org/10.2522/ptj.20070147.Search in Google Scholar PubMed
31. Sterne, JA, Savović, J, Page, MJ, Elbers, RG, Blencowe, NS, Boutron, I, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366. https://doi.org/10.1136/bmj.l4898.Search in Google Scholar PubMed
32. Nikfarjam, M, Parvin, N, Assarzadegan, N, Asghari, S. The effects of Lavandula angustifolia Mill infusion on depression in patients using citalopram: a comparison study. Iran Red Crescent Med J 2013;15:734–9. https://doi.org/10.5812/ircmj.4173.Search in Google Scholar PubMed PubMed Central
33. Bazrafshan, M-R, Jokar, M, Shokrpour, N, Delam, H. The effect of lavender herbal tea on the anxiety and depression of the elderly: a randomized clinical trial. Compl Ther Med 2020;50:102393. https://doi.org/10.1016/j.ctim.2020.102393.Search in Google Scholar PubMed
34. Kasper, S, Volz, HP, Dienel, A, Schläfke, S. Efficacy of Silexan in mixed anxiety-depression – a randomized, placebo-controlled trial. Eur Neuropsychopharmacol 2016;26:331–40. https://doi.org/10.1016/j.euroneuro.2015.12.002.Search in Google Scholar PubMed
35. Nikfarjam, M, Rakhshan, R, Ghaderi, H. Comparison of effect of Lavandula officinalis and venlafaxine in treating depression: a double blind clinical trial. J Clin Diagn Res 2017;11:KC01–4. https://doi.org/10.7860/JCDR/2017/20657.10233.Search in Google Scholar PubMed PubMed Central
36. Araj-Khodaei, M, Noorbala, AA, Yarani, R, Emadi, F, Emaratkar, E, Faghihzadeh, S, et al.. A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with fluoxetine for the treatment of depression. BMC Complement Med Ther 2020;20:207. https://doi.org/10.1186/s12906-020-03003-5.Search in Google Scholar PubMed PubMed Central
37. Akhondzadeh, S, Kashani, L, Fotouhi, A, Jarvandi, S, Mobaseri, M, Moin, M, et al.. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuro Psychopharmacol Biol Psychiatr 2003;27:123–7. https://doi.org/10.1016/s0278-5846(02)00342-1.Search in Google Scholar PubMed
38. Kamalifard, M, Khalili, AF, Namadian, M, Herizchi, S, Ranjbar, Y. Comparison of the effect of lavender and bitter orange on depression in menopausal women: a triple-blind randomized controlled trial. Int J Women’s Health Reprod Sci 2017;5:224–30. https://doi.org/10.15296/ijwhr.2017.40.Search in Google Scholar
39. Borenstein, M, Cooper, H, Hedges, L, Valentine, J. Effect sizes for continuous data. The handbook of research synthesis and meta-analysis. Russell Sage Foundation; 2009, 2:221–35 pp.Search in Google Scholar
40. Goel, N, Grasso, DJ. Olfactory discrimination and transient mood change in young men and women: variation by season, mood state, and time of day. Chronobiol Int 2004;21:691–719. https://doi.org/10.1081/cbi-200025989.Search in Google Scholar PubMed
41. Bahrami, T, Rejeh, N, Heravi-Karimooi, M, Vaismoradi, M, Tadrisi, SD, Sieloff, C. Effect of aromatherapy massage on anxiety, depression, and physiologic parameters in older patients with the acute coronary syndrome: a randomized clinical trial. Int J Nurs Pract 2017;23. https://doi.org/10.1111/ijn.12601.Search in Google Scholar PubMed
42. Moon, S-A, Bae, J, Kim, K-S, Cho, SY, Kwon, G, Lee, R, et al.. Essential oil fragrances positively affect menopausal depressive and anxiety symptoms: an EEG study for mid-life women. IBRO Rep 2019;6. https://doi.org/10.1016/j.ibror.2019.07.594.Search in Google Scholar
43. Fißler, M, Quante, A. A case series on the use of lavendula oil capsules in patients suffering from major depressive disorder and symptoms of psychomotor agitation, insomnia and anxiety. Compl Ther Med 2014;22:63–9. https://doi.org/10.1016/j.ctim.2013.11.008.Search in Google Scholar PubMed
44. Itai, T, Amayasu, H, Kuribayashi, M, Kawamura, N, Okada, M, Momose, A, et al.. Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatr Clin Neurosci 2000;54:393–7. https://doi.org/10.1046/j.1440-1819.2000.00727.x.Search in Google Scholar PubMed
45. Baniya, GC, Tyagi, A, Huda, N, Mishra, DS, Sharma, P. Comparative efficacy and safety of a herbal preparation along with Shirodhara therapy and fluoxetine in the treatment of major depressive disorder. Indian J Psychiatr 2013;55:S36.Search in Google Scholar
46. Fulzele, AV, Ingle, N, Huda, MN, Mishra, DS. Comparative study to evaluate the effect of a herbal preparation & shirodhara in the management of major depressive disorder. Int J Pharmtech Res 2014;6:506–11.Search in Google Scholar
47. Xiong, M, Li, Y, Tang, P, Zhang, Y, Cao, M, Ni, J, et al.. Effectiveness of aromatherapy massage and inhalation on symptoms of depression in Chinese community-dwelling older adults. J Alternative Compl Med 2018;24:717–24. https://doi.org/10.1089/acm.2017.0320.Search in Google Scholar PubMed
48. Sadat Firoozeei, T, Barekatain, M, Karimi, M, Zargaran, A, Akhondzadeh, S, Rezaeizadeh, H. Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: a double-blind randomized trial. J Integr Med 2020;18:409–15. https://doi.org/10.1016/j.joim.2020.06.002.Search in Google Scholar PubMed
49. Donelli, D, Antonelli, M, Bellinazzi, C, Gensini, GF, Firenzuoli, F. Effects of lavender on anxiety: a systematic review and meta-analysis. Phytomedicine 2019;65:153099. https://doi.org/10.1016/j.phymed.2019.153099.Search in Google Scholar PubMed
50. Fismer, KL, Pilkington, K. Lavender and sleep: a systematic review of the evidence. Eur J Integr Med 2012;4:e436–47. https://doi.org/10.1016/j.eujim.2012.08.001.Search in Google Scholar
51. Kianpour, M, Mansouri, A, Mehrabi, T, Asghari, G. Effect of lavender scent inhalation on prevention of stress, anxiety and depression in the postpartum period. Iran J Nurs Midwifery Res 2016;21:197–201. https://doi.org/10.4103/1735-9066.178248.Search in Google Scholar PubMed PubMed Central
52. Jafari-Koulaee, A, Khenarinezhad, F, Sharifi Razavi, A, Bagheri-Nesami, M. The effect of aromatherapy with lavender essence on depression and headache disability in migraine patients: a randomized clinical trial. J Med Plants 2019;18:162–72. https://doi.org/10.29252/jmp.2.70.162.Search in Google Scholar
53. Effati-Daryani, F, Mohammad-Alizadeh-Charandabi, S, Mirghafourvand, M, Taghizadeh, M, Mohammadi, A. Effect of lavender cream with or without foot-bath on anxiety, stress and depression in pregnancy: a randomized placebo-controlled trial. J Caring Sci 2015;4:63–73. https://doi.org/10.5681/jcs.2015.007.Search in Google Scholar PubMed PubMed Central
54. Soden, K, Vincent, K, Craske, S, Lucas, C, Ashley, S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004;18:87–92. https://doi.org/10.1191/0269216304pm874oa.Search in Google Scholar PubMed
55. Lavender. Drugs and lactation database (LactMed). Bethesda (MD): National Library of Medicine (US); 2006.Search in Google Scholar
56. Kahkeshani, N, Khanavi, M, Hadjiakhoondi, A. Differentiation of Lavandula angustifolia Mill. and Nepeta menthoides Boiss & Buhse using microscopic and phytochemical evaluations. In: 3rd National Congress on Medicinal Plants. Mashhad-Iran; 2014.Search in Google Scholar
57. Lawrence, BM. Essential oil production. Biogeneration of aromas. American Chemical Society; 1986:363–9. https://doi.org/10.1021/bk-1986-0317.ch027.Search in Google Scholar
58. Sabogal-Guáqueta, AM, Hobbie, F, Keerthi, A, Oun, A, Kortholt, A, Boddeke, E, et al.. Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity. Biomed Pharmacother 2019;118:109295. https://doi.org/10.1016/j.biopha.2019.109295.Search in Google Scholar PubMed
59. Newmaster, SG, Grguric, M, Shanmughanandhan, D, Ramalingam, S, Ragupathy, S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med 2013;11:222. https://doi.org/10.1186/1741-7015-11-222.Search in Google Scholar PubMed PubMed Central
60. Basch, E, Foppa, I, Liebowitz, R, Nelson, J, Smith, M, Sollars, D, et al.. Lavender (Lavandula angustifolia Miller). J Herb Pharmacother 2004;4:63–78. https://doi.org/10.1080/j157v04n02_07.Search in Google Scholar
61. Kamalifard, M, Farshbaf-Khalili, A, Namadian, M, Ranjbar, Y, Herizchi, S. Comparison of the effect of lavender and bitter orange on sleep quality in postmenopausal women: a triple-blind, randomized, controlled clinical trial. Women Health 2018;58:851–65. https://doi.org/10.1080/03630242.2017.1353575.Search in Google Scholar PubMed
62. Hengartner, MP, Plöderl, M. Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work: effect size and method bias matter! Front Psychiatr 2018;9:517. https://doi.org/10.3389/fpsyt.2018.00517.Search in Google Scholar PubMed PubMed Central
63. Moncrieff, J, Kirsch, I. Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemp Clin Trials 2015;43:60–2. https://doi.org/10.1016/j.cct.2015.05.005.Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/jcim-2020-0498).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
